
1: Merentitis D, Nguyen BD, Samartzis EP, Noske A, Brandt S, Dedes KJ. Loss of
MDC1 in Endometrial Carcinoma Is Associated With Loss of MRN Complex and MMR
Deficiency. Anticancer Res. 2019 Dec;39(12):6547-6553. doi:
10.21873/anticanres.13870. PubMed PMID: 31810920.


2: Petrelli F, Ghidini M, Cabiddu M, Pezzica E, Corti D, Turati L, Costanzo A,
Varricchio A, Ghidini A, Barni S, Tomasello G. Microsatellite Instability and
Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
Anticancer Res. 2019 Dec;39(12):6431-6441. doi: 10.21873/anticanres.13857.
Review. PubMed PMID: 31810907.


3: Wild PJ. [Importance of tumour mutation burden testing]. Pathologe. 2019
Dec;40(Suppl 3):366-368. doi: 10.1007/s00292-019-00717-3. German. PubMed PMID:
31807843.


4: Razavi P, Li BT, Brown DN, Jung B, Hubbell E, Shen R, Abida W, Juluru K, De
Bruijn I, Hou C, Venn O, Lim R, Anand A, Maddala T, Gnerre S, Vijaya Satya R, Liu
Q, Shen L, Eattock N, Yue J, Blocker AW, Lee M, Sehnert A, Xu H, Hall MP,
Santiago-Zayas A, Novotny WF, Isbell JM, Rusch VW, Plitas G, Heerdt AS, Ladanyi
M, Hyman DM, Jones DR, Morrow M, Riely GJ, Scher HI, Rudin CM, Robson ME, Diaz LA
Jr, Solit DB, Aravanis AM, Reis-Filho JS. High-intensity sequencing reveals the
sources of plasma circulating cell-free DNA variants. Nat Med. 2019
Dec;25(12):1928-1937. doi: 10.1038/s41591-019-0652-7. Epub 2019 Nov 25. PubMed
PMID: 31768066; PubMed Central PMCID: PMC7061455.


5: van Dessel LF, van Riet J, Smits M, Zhu Y, Hamberg P, van der Heijden MS,
Bergman AM, van Oort IM, de Wit R, Voest EE, Steeghs N, Yamaguchi TN, Livingstone
J, Boutros PC, Martens JWM, Sleijfer S, Cuppen E, Zwart W, van de Werken HJG,
Mehra N, Lolkema MP. The genomic landscape of metastatic castration-resistant
prostate cancers reveals multiple distinct genotypes with potential clinical
impact. Nat Commun. 2019 Nov 20;10(1):5251. doi: 10.1038/s41467-019-13084-7.
PubMed PMID: 31748536; PubMed Central PMCID: PMC6868175.


6: Reynolds IS, O'Connell E, Fichtner M, McNamara DA, Kay EW, Prehn JHM, Furney
SJ, Burke JP. Mucinous adenocarcinoma of the colon and rectum: A genomic
analysis. J Surg Oncol. 2019 Dec;120(8):1427-1435. doi: 10.1002/jso.25764. Epub
2019 Nov 14. PubMed PMID: 31729037.


7: Katafygiotis P, Sakellariou S, Chatziandreou I, Giannopoulou I, Thymara I,
Saetta AA, Korkolopoulou P. Microsatellite Instability in Greek Colorectal
Carcinoma Patients: Clinicopathological and Molecular Correlations. Anticancer
Res. 2019 Nov;39(11):6379-6387. doi: 10.21873/anticanres.13851. PubMed PMID:
31704871.


8: Fehniger JE, Berger AA, Juckett L, Elvin J, Levine DA, Zajchowski DA.
Comprehensive genomic sequencing of paired ovarian cancers reveals discordance in
genes that determine clinical trial eligibility. Gynecol Oncol. 2019
Dec;155(3):473-482. doi: 10.1016/j.ygyno.2019.10.004. Epub 2019 Nov 6. PubMed
PMID: 31703812.


9: Brandl L, Horst D, Gr√ºnewald TGP, Mayerle J, Sendelhofert A, Neumann J,
Kirchner T, De Toni EN. Clinical Evidence on the Interaction Between MLK4, KRAS
and Microsatellite Instability to Determine the Prognosis of Early-Stage
Colorectal Carcinoma. Cell Physiol Biochem. 2019;53(5):820-831. doi:
10.33594/000000175. PubMed PMID: 31701729.


10: Evans SJ, Gollapudi B, Moore MM, Doak SH. Horizon scanning for novel and
emerging in vitro mammalian cell mutagenicity test systems. Mutat Res. 2019
Nov;847:403024. doi: 10.1016/j.mrgentox.2019.02.005. Epub 2019 Feb 21. Review.
PubMed PMID: 31699342.

